Stay updated with breaking news from Inhalation Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In a renewed partnership Karolinska Institutet in Stockholm will help validate ISAB's new XposeALI® MP tool, including using it to test a Mars dust surrogate for the European Space Agency... | October 12, 2021
Published: May 13, 2021 By Alex Keown Akouos, Inc. – Kathy Reape was named chief development officer of Boston-based Akouos. Reape most recently served as chief medical officer at Spark Therapeutics where she oversaw clinical development, pharmacovigilance, and medical affairs activities. Reape was a key member of the team responsible for the development and commercialization of Luxturna, the first FDA-approved in vivo gene therapy approved for an inherited retinal disease caused by mutations in both copies of the RPE65 gene. Prior to Spark, Reape was senior vice president of clinic...
April 20, 2021) Inhalation Sciences (ISAB) has signed an agreement with prestigious lead generation company Cience and with Coelus Bio, a boutique CRO consulting firm specialized in inhalation drug development, to generate new leads and sales in the US. It is part of the marketing activities aimed at growing ISAB's sales and presence in the US, a strategic goal for 2021, and becoming a clear market leader in its niche. With strengthened sales in 2020 ISAB identified expanding its marketing and sales activities as a vital strategy for 2021, aiming to expand sales in the US . In December 2020...
Inhalation Sciences Sweden : news roundup spring 2021 03/03/2021 | 05:04am EDT Send by mail : Message : AQUILON PHARMA PURCHASES PRECISEINHALE FOR INNOVATIVE ASTHMA AND COPD RESEARCH Aquilon Pharma, based in Belgium, has purchased ISAB's high-precision R&D system PreciseInhale®, plus its Nose-Only and Intratracheal Exposure Modules, to help drive forward their innovative portfolio of new formulations to improve the efficacy of inhaled drugs for asthma and COPD (Chronic Pulmonary Obstructive disorder). IT FOR 'ADVANCED AUTOMATION, USABILITY AND FLEXIBILITY' Graz University's ...
Toronto, ON (PRWEB) March 03, 2021 -- Inhaled studies are often perceived as technically challenging, and varied regulations around the world add another